HOPPS, Eugenia
 Distribuzione geografica
Continente #
NA - Nord America 7.244
EU - Europa 3.164
AS - Asia 2.581
SA - Sud America 510
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 67
OC - Oceania 7
Totale 13.823
Nazione #
US - Stati Uniti d'America 7.109
IT - Italia 1.014
SG - Singapore 962
RU - Federazione Russa 658
CN - Cina 562
BR - Brasile 376
FI - Finlandia 317
HK - Hong Kong 253
VN - Vietnam 226
DE - Germania 213
PL - Polonia 154
UA - Ucraina 153
GB - Regno Unito 150
FR - Francia 146
IE - Irlanda 139
KR - Corea 104
BD - Bangladesh 85
IN - India 79
JP - Giappone 79
CA - Canada 62
NL - Olanda 59
SE - Svezia 46
TR - Turchia 37
IQ - Iraq 32
MX - Messico 30
AR - Argentina 28
CO - Colombia 28
EC - Ecuador 23
RO - Romania 21
PK - Pakistan 19
CL - Cile 18
BE - Belgio 17
ES - Italia 17
CI - Costa d'Avorio 15
IR - Iran 15
UZ - Uzbekistan 14
ID - Indonesia 13
ZA - Sudafrica 13
MY - Malesia 12
VE - Venezuela 12
AT - Austria 11
SA - Arabia Saudita 11
CR - Costa Rica 10
IL - Israele 10
MA - Marocco 10
UY - Uruguay 9
KE - Kenya 8
NP - Nepal 8
PH - Filippine 8
JM - Giamaica 7
AU - Australia 6
KZ - Kazakistan 6
LB - Libano 6
NI - Nicaragua 6
PE - Perù 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AM - Armenia 5
BG - Bulgaria 5
CH - Svizzera 5
PY - Paraguay 5
AL - Albania 4
BO - Bolivia 4
EE - Estonia 4
EG - Egitto 4
HN - Honduras 4
JO - Giordania 4
LT - Lituania 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CY - Cipro 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DZ - Algeria 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
BB - Barbados 2
BF - Burkina Faso 2
BH - Bahrain 2
BZ - Belize 2
GT - Guatemala 2
MN - Mongolia 2
NG - Nigeria 2
NO - Norvegia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
Totale 13.566
Città #
Ashburn 795
Fairfield 739
Singapore 613
San Jose 513
Houston 464
Chandler 362
Woodbridge 359
Wilmington 310
Seattle 308
Cambridge 280
Hong Kong 237
Ann Arbor 202
Council Bluffs 196
Palermo 152
Dublin 140
Zgierz 130
Santa Clara 118
Medford 116
Des Moines 109
Beijing 107
Moscow 106
Dallas 85
Nanjing 83
Jacksonville 78
Tokyo 77
Boardman 76
Princeton 76
Los Angeles 73
Altamura 69
Lauterbourg 67
New York 63
Ho Chi Minh City 60
Hanoi 56
Lawrence 51
Rome 48
Frankfurt am Main 46
Helsinki 46
Milan 45
San Diego 42
The Dalles 39
Dearborn 35
Munich 33
Shenyang 31
Tulsa 30
Chicago 29
Phoenix 26
Seongnam 26
Buffalo 24
São Paulo 23
Jiaxing 20
London 19
Hebei 18
Nanchang 18
Tianjin 18
Atlanta 17
Jinan 17
Columbus 16
Naples 16
Abidjan 15
Brussels 15
Da Nang 15
Rio de Janeiro 15
Faridabad 14
Ludwigshafen am Rhein 14
Ningbo 14
Orem 14
Philadelphia 14
Florence 13
Guangzhou 13
Redwood City 13
Toronto 13
Changsha 12
Paris 12
Santiago 12
Venice 12
Warsaw 12
Belo Horizonte 11
Brooklyn 11
Chennai 11
Kumar 11
Saint Petersburg 11
Washington 11
Amsterdam 10
Campinas 10
Falls Church 10
Haiphong 10
Orange 10
San Paolo di Civitate 10
Tashkent 10
Tehran 10
Baghdad 9
Denver 9
Dhaka 9
Hefei 9
Kuala Lumpur 9
Montreal 9
Quito 9
San José 9
Zhengzhou 9
Cagliari 8
Totale 8.429
Nome #
Alterazioni emoreologiche nella sindrome metabolica 555
Clinical conditions responsible for hyperviscosity and skin ulcers complications 457
Lipid Peroxidation, Protein Oxidation, Gelatinases, and Their Inhibitors in a Group of Adults with Obesity 381
Behaviour of the neutrophil to lymphocyte ratio in young subjects with acute myocardial infarction 337
Aspetti emoreologici nella iperviscosità policitemica e sierica 290
Behavior of the total antioxidant status in a group of subjects with metabolic syndrome. 286
Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers. 278
Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment 265
Analysis of the Blood Viscosity Behavior in the Sicilian Study on Juvenile Myocardial Infarction 260
A novel component of the metabolic syndrome : The oxidative stress 248
Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS) 240
Erythrocyte deformability and hemorheological profile in multiple myeloma 239
Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome 234
Effects of exercise on inflammation markers in type 2 diabetic subjects. 233
Lipid peroxidation and nitric oxide metabolites in a group of subjects with obstructive sleep apnea syndrome 222
Hemorheological abnormalities in human arterial hypertension 219
Erythrocyte deformability, plasma lipid peroxidation and plasma protein oxidation in a group of OSAS subjects 218
Leucociti polimorfonucleati e diabete mellito 212
Clinical disorders responsible for plasma hyperviscosity and skin complications 210
Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey 202
Lipid Peroxidation, Nitric Oxide Metabolites, and Their Ratio in a Group of Subjects with Metabolic Syndrome 201
Polymorphonuclear leukocytes and diabetes mellitus. 191
Protein oxidation in a group of subjects with metabolic syndrome. 191
Deformabilità eritrocitaria, metaboliti dell'ossido nitrico e stress ossidativo in un gruppo di soggetti con sindrome delle apnee ostruttive nel sonno 191
Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome. 189
Gelatinases and physical exercise: A systematic review of evidence from human studies 185
Fluidity and cytosolic Ca2+ concentration of circulating polymorphonuclear leukocytes at baseline in some chronic and acute clinical conditions: review of our survey 184
Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome. 181
Protein oxidation in chronic kidney disease 181
Analysis of the correlations between oxidative stress, gelatinases and their tissue inhibitors in the human subjects with obstructive sleep apnea syndrome 181
Nitric oxide metabolites (nitrite and nitrate) in several clinical condition 179
Red blood cell deformability in multiple myeloma 178
Deformabilità eritrocitaria e metaboliti dell'ossido nitrico in un gruppo di soggetti con sindrome delle apnee ostruttive nel sonno 176
Nitric oxide metabolites and oxidative stress in mild essential hypertension 174
Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects 167
Emoreologia ed ipertensione 167
Pathophysiology of polymorphonuclear leukocyte in arterial hypertension. 166
Interrelazioni tra disfunzione endoteliale e stress ossidativo; valutazione della perossidazione lipidica in particolari quadri clinici 166
PULMONARY EMBOLISM IN AN EMERGENCY CARE UNIT: EVALUATION OF PREDICTIVE FACTORS FROM CLINICAL HISTORY AND PHYSICAL EXAM 166
Study of the Correlations among Some Parameters of the Oxidative Status, Gelatinases, and Their Inhibitors in a Group of Subjects with Metabolic Syndrome 165
Oxidative status in metabolic syndrome 163
Alterazioni funzionali leucocitarie nella malattia ipertensiva 161
Plasma Viscosity and NLR in Young Subjects with Myocardial Infarction: Evaluation at the Initial Stage and at 3 and 12 Months 161
Protein oxidation in metabolic syndrome 156
Profilo emoreologico nell'infarto miocardico giovanile: nuove acquisizioni 156
Gelatinases and their tissue inhibitors in metabolic syndrome 154
Iperviscosita' sclerocitemica da alterazioni congenite della membrana eritrocitaria 153
Hemorheological abnormalities in human arterial hypertension 153
Comportamento delle gelatinasi e dei loro inibitori tissutali nella sindrome metabolica 153
Protein oxidation in mild essential hypertension 153
Portopulmonary hypertension 147
Lipid peroxidation and protein oxidation are related to the severity of OSAS 147
Oxidative status in nondiabetic middle-aged subjects with metabolic syndrome: preliminary data. 145
Studio dei parametri dello stress ossidativo e della reologia eritrocitaria in soggetti affetti da sindrome delle apnee ostruttive nel sonno (OSAS) 144
Eventi vascolari correlati ad alcune condizioni di iperviscosità sclerocitemica 141
La microangiopatia diabetica 139
Exercise in obesity management 139
Molecole di adesione e malattia diabetica 138
Matrix metalloproteinases in metabolic syndrome. 137
Deformabilità eritrocitaria nella policitemia vera 137
Metabolic syndrome: from insulin resistance to adipose tissue dysfunction. 135
Protein carbonyl groups in trained subjects before and after a cardiopulmonary test 135
Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome 133
Short-Term Prognosis of Juvenile Myocardial Infarction: Role of Plasma Viscosity 133
Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome 127
Studio delle interrelazioni tra stress ossidativo, gelatinasi e loro inibitori in soggetti con sindrome delle apnee ostruttive nel sonno 126
Metalloproteinasi, stress ossidativo e sindrome metabolica 124
Membrane fluidity and cytosolic Ca2+ concentration of the circulating polymorphonuclear leukocytes in diabetes mellitus 121
Lipid peroxidation and protein oxidation are related to the severity of OSAS 115
The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey 114
Polymorphonuclear leukocyte rheology, cytosolic Ca2+ content, beta2-integrin expression and oxidative stress in hypertension. 113
Ulcere venose: rilievi riguardanti sia aspetti reologici e funzionali dei polimorfonucleati che le concentrazioni plasmatiche delle gelatinasi e dei loro inibitori 108
PMN membrane fluidity, cytosolic Ca2+ content and beta2-integrin pattern in vascular atherosclerotic disease 101
Haemorheological profile in congenital afibrinogenemia and in congenital dysfibrinogenemia: A clinical case report 96
Totale 13.823
Categoria #
all - tutte 45.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.945


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022608 0 0 0 50 22 36 29 61 102 90 70 148
2022/20231.097 112 207 19 113 126 165 81 69 126 3 47 29
2023/2024506 27 85 46 46 49 79 47 19 6 22 29 51
2024/20251.511 45 143 170 110 63 65 102 113 91 122 206 281
2025/20264.154 261 103 224 241 314 581 711 456 342 580 178 163
2026/20271.037 261 140 618 18 0 0 0 0 0 0 0 0
Totale 13.823